Crossmark

Management of Drug-Induced Epidermal Necrolysis (DEN) in Pediatric Patients: Moving from Drug-Induced Stevens–Johnson Syndrome, Overlap and Toxic Epidermal Necrolysis to a Single Unifying Diagnosis of DEN

Crossref DOI link: https://doi.org/10.1007/s40272-022-00515-0

Published Online: 2022-06-09

Published Print: 2022-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ramien, Michele L. https://orcid.org/0000-0001-9191-3611
Mansour, Danny

Shear, Neil H.
License Information

Text and Data Mining valid from 2022-06-09

Version of Record valid from 2022-06-09
More Information

Article History

Accepted: 26 April 2022

First Online: 9 June 2022

Declarations

:

: Not applicable.

: Michele Ramien has received research funding from the Pediatric Dermatology Research Alliance for a project on pediatric SJS-TEN. Danny Mansour and Neil Shear have no conflicts of interest to declare.

: Not applicable.

: Not applicable.

: All authors consent to publication of this work.

: Not applicable.

: Not applicable.

: MR drafted and revised the manuscript. DM and NS critically reviewed and revised the manuscript.

Document is current

Any future updates will be listed below